Terrie Curran

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Latha Vairavan, as Attorney-in-Fact for Terrie Curran
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Terrie Curran

Form 4 holding President and Chief Executive, Director

Phathom Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
360,465
Estimated value
$2,374,635
Report date
21 Jan 2025
Price
$6.59
Ownership
Direct
Form 4 holding President and Chief Executive, Director

Phathom Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
3,840
Estimated value
$25,298
Report date
21 Jan 2025
Price
$6.59
Ownership
By 401(k)
Form 4 holding President and Chief Executive, Director

Phathom Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
342,500
Estimated value
Report date
27 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Myovant Sciences Ltd.

Security class
Common Shares
Shares / value
0
Estimated value
Report date
10 Mar 2023
Price
$27.00
Ownership
Direct
Form 4 holding Director

Myovant Sciences Ltd.

Security class
Stock Options (Right to Buy)
Shares / value
0
Estimated value
Report date
10 Mar 2023
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Insider Reports Filed by Terrie Curran

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .